The fight to defeat cancer has seen many people make effort to deliver solutions that can be used in the long term to help patients. One of the individuals who have stood out in this regard is Clay Siegall, who has invested a lot in cancer research and the development of products that are meant to offer easier and highly reliable methods of treating cancer. As a clinical scientist with over 20 years experience, Clay Siegall has helped many experts who work under him to pursue research projects that later led to the development of useful drug pipelines.
He founded Seattle Genetics in 1998 and has been working as the President and CEO of the company. His leadership has been a major boost to the development of the company and the engineering of solutions that are powerful and meant to advance the fight to find better ways of treating cancer. Through his company, Clay Siegall has launched several technologies and one of the most notable is the ADC Technology, which was rated perfectly as a solution to the many challenges that have been preventing the successful administration of treatment to cancer patients. The technology works by carefully selecting the harmful cells and destroying them while discriminating against the healthy ones.
About Clay Siegall
Clay Siegall, who has worked in the field of biotechnology for over 20 years, is the founder and CEO of renowned biotechnology company, Seattle Genetics. He is a passionate researcher and his support for cancer research led to the development of powerful solutions for the treatment of cancer. Clay Siegall has also been inviting support to make the process a success and in this bid, he was able to launch the ADC Technology and ADCETRIS, which have proved useful in the fight against cancer.
His educational background places him among clinical scientists. He first earned a bachelor’s degree in Zoology at the University of Maryland then later joined the University of Washington for a PhD degree in Genetics. He sharpened his skills along the way while working with several companies and corporations like the National Institute of Health.